Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease

Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer’s disease

Abstract Background Ongoing efforts within the Alzheimer’s disease (AD) field have focused on improving the intra- and inter-laboratory variability for cerebrospinal fluid (CSF) biomarkers. Fully automated assays offer the possibility to eliminate sample manipulation steps and are expected to contri...

Full description

Bibliographic Details
Main Authors: Maria João Leitão, Anuschka Silva-Spínola, Isabel Santana, Veronica Olmedo, Alicia Nadal, Nathalie Le Bastard, Inês Baldeiras
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
Cerebrospinal fluid
Biomarkers
Chemiluminescent enzyme-automated immunoassay
Online Access:http://link.springer.com/article/10.1186/s13195-019-0550-8

Internet

http://link.springer.com/article/10.1186/s13195-019-0550-8

Similar Items